Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 59.20 · gapped below the open, then crossed back over prior close. High/low 59.32 at 9:45 am ET, 58.44 at 10:45 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Lonza will be a preferred, non-exclusive, supplier of the Products to us, and we retain the right to procure the Products from one or more alternate and/or backup manufacturers of the Products (including at our own facilities).”
FILING10-K0001649094-26-000007cik 0001649094
“In September 2025, we announced a new agreement with Patheon Manufacturing Services, LLC, part of Thermo Fisher Scientific (collectively, "Thermo Fisher") to provide custom commercial fill-finish capacity for our broad-spectrum PCVs at Thermo Fisher's Greenville, North Carolina facility.”
FILING10-K0001649094-26-000007cik 0001649094
“In November 2023, we entered into a manufacturing rights agreement (the "Manufacturing Rights Agreement") with Sutro Biopharma pursuant to which we obtained exclusive rights to independently, or through certain third parties, develop, improve and manufacture cell-free extract for use in connection with our vaccine candidates.”
FILING10-K0001649094-26-000007cik 0001649094
“We are party to a license agreement with the University of California, San Diego, dated February 4, 2019, which was subsequently amended on August 16, 2019 (as amended, the "UCSD License") whereby we are the exclusive licensee of an issued U.S. patent and pending U.S. patent application related to a non-cross-reactive Group A Strep carbohydrate antigen and methods of producing the antigen.”
FILING10-K0001649094-26-000007cik 0001649094
Watchlist prices, news filtered to it, and its next report on your desk.
Vaxcyte, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Vaxcyte, Inc. has 4 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Vaxcyte, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Vaxcyte, Inc.. Customers appear here when Vaxcyte, Inc. names them, or when a company names Vaxcyte, Inc. as a supplier in its own annual report.
PCVX (Vaxcyte, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: TMO −0.14%, in healthcare.